111 (YI) EBITDA (2017 - 2025)
111's (YI) quarterly EBITDA came in at -$2.4 million in Q4 2025, up 4.04% year-on-year from -$2.3 million in Q4 2024, and down 26.89% quarter-over-quarter from -$1.9 million in Q3 2025.
111 (YI) EBITDA (2017 - 2025) Analysis & Trends
111 has disclosed EBITDA across 9 years of filings, most recently posting -$2.4 million for Q4 2025.
- EBITDA for Q4 2025 came in at -$2.4 million, up 4.04% year-over-year; the trailing twelve-month figure through Dec 2025 was -$9.5 million (down 9.1% YoY), and the FY2025 annual result was -$9.7 million, down 13.03% from the prior year.
- EBITDA came in at -$2.4 million for Q4 2025 at 111, down from -$1.9 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$1.8 million in Q1 2024 to a low of -$39.1 million in Q3 2021.
- The 5-year median for EBITDA is -$9.5 million (2022), against an average of -$11.9 million.
- Across the five-year window, EBITDA tumbled 108.93% in 2021 and surged 91.93% in 2024, its largest moves.
- 111's EBITDA stood at -$18.0 million in 2021, then grew by 5.3% to -$17.0 million in 2022, then plunged by 80.42% to -$30.7 million in 2023, then soared by 91.93% to -$2.5 million in 2024, then grew by 4.04% to -$2.4 million in 2025.
- The last three EBITDA figures came in at -$2.4 million (Q4 2025), -$1.9 million (Q3 2025), and -$2.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 2.15 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.27 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 509.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 182.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 46.01 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -7.37 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -2.38 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -3.10 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.38 Mn |
| Sep 30, 2025 | -1.87 Mn |
| Jun 30, 2025 | -2.85 Mn |
| Mar 31, 2025 | -2.44 Mn |
| Dec 31, 2024 | -2.48 Mn |
| Sep 30, 2024 | -2.61 Mn |
| Jun 30, 2024 | -1.86 Mn |
| Mar 31, 2024 | -1.80 Mn |
| Dec 31, 2023 | -30.71 Mn |
| Sep 30, 2023 | -13.00 Mn |
| Jun 30, 2023 | -6.65 Mn |
| Mar 31, 2023 | -5.05 Mn |
| Dec 31, 2022 | -17.02 Mn |
| Sep 30, 2022 | -12.25 Mn |
| Jun 30, 2022 | -13.10 Mn |
| Mar 31, 2022 | -17.56 Mn |
| Dec 31, 2021 | -17.97 Mn |
| Sep 30, 2021 | -39.06 Mn |
| Jun 30, 2021 | -25.11 Mn |
| Mar 31, 2021 | -22.13 Mn |